Service description
Our clients in the biotech and venture capital communities tell us that
a
lack of boardroom skills can be an inhibitor to growth.
Small companies, especially early stage, are necessarily focused on
developing their product/technology and managing their limited resources.
They need also to develop a way of seeing the bigger commercial picture.
The
use of highly experienced professionals playing an active role as a non-exec
is a way of achieving this. The right individuals will also come with
valuable industry contacts. The recent Higgs Review also emphasised the
value of independent non-executive directors to good corporate governance
and the impact this has on attracting inward investment.
The Harten Group has a pool of executive talent, drawn specifically from
the
life sciences industry, either large pharmaceutical or biotech companies.
With over 750 consultants in our network, we can find suitable candidates
to
strengthen the skill base of company boards. We understand also the need
for speed and confidentiality. As these professionals are already known
to
us, we can progress from enquiry to shortlist to meeting in just one week.
Our fee structure is also geared to start-ups and smaller companies -
a
one-off flat fee of £5,000 payable only on a successful introduction.
|